# Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve System in Patients With Severe Calcific Aortic Stenosis

Study · id `cardio:ct-nct04815785` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04815785](<https://clinicaltrials.gov/study/NCT04815785>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04815785

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

## Technical summary

Registry record NCT04815785. Allocation not applicable; no masking; primary purpose treatment. Start 2017-09-22 (actual); primary completion 2020-05-11 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 120 participants (planned count; ClinicalTrials.gov record NCT04815785, source copy `cardio:ctgov-nct04815785-2023-10-24`, retrieved 2026-10-26)
- Started: 2017-09-22 (actual) (ClinicalTrials.gov record NCT04815785, source copy `cardio:ctgov-nct04815785-2023-10-24`, retrieved 2026-10-26)
- Primary completion: 2020-05-11 (actual) (ClinicalTrials.gov record NCT04815785, source copy `cardio:ctgov-nct04815785-2023-10-24`, retrieved 2026-10-26)
- Completion: 2024-05-30 (anticipated) (ClinicalTrials.gov record NCT04815785, source copy `cardio:ctgov-nct04815785-2023-10-24`, retrieved 2026-10-26)
- Countries: China (ClinicalTrials.gov record NCT04815785, source copy `cardio:ctgov-nct04815785-2023-10-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04815785-2023-10-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of TaurusOne® Transcatheter Aortic Valve System in Patients With Severe Calcific Aortic Stenosis
- Condition: Aortic Stenosis
- Intervention (Device): TaurusOne® transcatheter aortic valve replacement system
- Lead sponsor: Peijia Medical Technology (Suzhou) Co., Ltd.
- Lead sponsor class: INDUSTRY
- Collaborator: Fu Wai Hospital, Beijing, China
- Collaborator class: OTHER
- Collaborator: Second Affiliated Hospital, Zhejiang University, School of Medicine
- Collaborator class: OTHER
- Collaborator: West China Hospital
- Collaborator class: OTHER
- Collaborator: General Hospital of Shenyang Military Region
- Collaborator class: OTHER
- Collaborator: The Second Affiliated Hospital of Harbin Medical University
- Collaborator class: OTHER
- Collaborator: Second Xiangya Hospital of Central South University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Aortic stenosis (`cardio:aortic-stenosis`)
- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Peijia Medical Technology (Suzhou) Co., Ltd. (`cardio:org-peijia-medical-technology-suzhou-co-ltd`)
- Registry lists this organization as a collaborator: Fu Wai Hospital, Beijing, China (`cardio:org-fu-wai-hospital-beijing-china`)
- Registry lists this organization as a collaborator: Second Affiliated Hospital, Zhejiang University, School of Medicine (`cardio:org-second-affiliated-hospital-zhejiang-university-school-of-bfd3ac`)
- Registry lists this organization as a collaborator: West China Hospital (`cardio:org-west-china-hospital`)
- Registry lists this organization as a collaborator: General Hospital of Shenyang Military Region (`cardio:org-general-hospital-of-shenyang-military-region`)
- Registry lists this organization as a collaborator: The Second Affiliated Hospital of Harbin Medical University (`cardio:org-the-second-affiliated-hospital-of-harbin-medical-university`)
- Registry lists this organization as a collaborator: Second Xiangya Hospital of Central South University (`cardio:org-second-xiangya-hospital-of-central-south-university`)

## Provenance

Content hash: 24f363241f271ef5ee2a8c41a8adde4b5d62724dd49132429d47437850dd35c2
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
